CME and CFTC Locked in Battle Over On-Chain Perpetual Futures

The conflict between the CME Group and the US Commodity Futures Trading Commission (CFTC) has escalated, with the CME suing the CFTC over its decision to allow blockchain-based perpetual futures products. The CME argues that these products, which enable users to speculate on asset prices with leverage and no expiration date, are being mislabeled and that the CFTC is misapplying the law. The CFTC's move has been seen as a significant development in the rapidly growing arena of perpetual futures, with non-US perps volume reaching $60 trillion in volume last year. The CME claims that the CFTC's sudden embrace of these products did not consider the ramifications and that they are harmful to its long-dated futures products. The dispute has sparked frustration among those supporting the CFTC's reforming agenda, with some viewing the CME's actions as an attempt to maintain its dominance in the market. The CFTC's decision to allow perpetual futures has been seen as a significant shift in the regulator's approach, with some arguing that it could have far-reaching implications for the US approach to the crypto market. The CME's lawsuit argues that the CFTC's approval of perpetual futures was inappropriate and that the regulator failed to follow proper procedures. The case is currently awaiting federal court action, which could have significant influence on the future of the US crypto market. The CFTC's chairman, Mike Selig, has defended the regulator's decision, stating that the CME's actions are 'wholly inappropriate'. The dispute has also drawn in other industry players, with some arguing that the CFTC's approach is too hastily implemented and that it could lead to regulatory inconsistencies. The outcome of the case is likely to have significant implications for the US crypto market, with some arguing that it could determine the future of perpetual futures in the country.